NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients

@article{MasurelPaulet2008NTBCTI,
  title={NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients},
  author={Alice Masurel-Paulet and Jos{\'e}phine Poggi-Bach and M.-O. Rolland and Olivier Bernard and Nathalie Guffon and Dries Dobbelaere and Jacques Sarles and H{\'e}l{\`e}ne Ogier de Baulny and Guy Touati},
  journal={Journal of Inherited Metabolic Disease},
  year={2008},
  volume={31},
  pages={81-87}
}
We describe a retrospective study of long-term outcome of 46 patients treated and regularly followed in France with 2-(2-nitro-4-trifluoromethylbenzoyl)-1, 3-cyclohexanedione (NTBC) for tyrosinaemia type I. Most had initial good response with normalization of liver function and metabolic parameters. Only one infant had no response to treatment and required liver transplantation. Among the 45 long-term treated patients, three underwent secondary liver transplantation: one for cirrhosis and two… CONTINUE READING
47 Citations
21 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 47 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Outcome of tyrosinemia type III

  • CJ Ellaway, E Holme, S Standing
  • J Inherit Metab Dis
  • 2001
1 Excerpt

Similar Papers

Loading similar papers…